Neil H. Aronson


Neil H. Aronson Portrait



  • Cornell Law School, J.D.
  • Boston University, B.A. American Civilization/English Literature, summa cum laude, Phi Beta Kappa


Lawyer Bio

Neil H. Aronson is one of New England’s most respected corporate and securities lawyers. Boston Magazine has recognized Neil on multiple occasions (including in its most recent surveys in each of 2018 and 2019) as one of Boston’s Top 100 Lawyers and Neil also holds Martindale-Hubbell’s AV®Preeminent rating – ranking him at the highest level of professional excellence. Neil represents many innovative and growing companies, many of them leading edge developers of new technologies in high technology, social media, medical devices and life sciences as well as rapidly growing service-based and retail businesses, as well as larger companies seeking to grow through acquisitions and joint ventures.

Read More

    Thought Leadership

    “Representations, Warranties, Indemnification & Termination Clauses” Massachusetts Continuing Legal Education (2015-16), Chair & Editor

    “Investor Rights Agreements” published in Venture Capital Forms and Analysis (Law Journal Press, 2007)

    Management Retention Plans Corporate Board Journal, (Spring 2006)

    “Themes on Corporate Governance” Journal of Commercial Biotechnology, (September 2003)

    Strategies and Best Practices in Outsourcing Agreements, Massachusetts Continuing Legal Education (2004)

    “Preventing Future Enrons: Implementing the Sarbanes-Oxley Act of 2002” (Stanford Journal of Law and Business, Autumn 2002)

    Venture Capital Financing Documents” Massachusetts Continuing Legal Education (2000)

    “Representing a High Tech Startup,” Massachusetts Continuing Legal Education (2000)

    “Financing Strategies for the Public Company,” Massachusetts Continuing Legal Education (1998)

    Representative Engagements

    Applied Science and Technology, Inc (NASDAQ: ASTX)
    Neil served as ASTEX’s outside counsel from its formation in 1987 through three private funding rounds, an IPO, two follow-on public offerings, six acquisitions and its merger with MKS Instruments, Inc.

    Connected Corporation
    Neil represented Connected Corporation in connection with its acquisition of RChive-It, Ltd. and its acquisition by Iron Mountain Corporation (NYSE: IRM), one of the largest venture capital backed company sales.

    Icoria, Inc. (NASDAQ: ICOR)
    Neil has represented Icoria in a follow-on public offering through J.P. Morgan Chase; a subsequent convertible debt financing, the acquisition of Tissue Informatics, Inc. the disposition of Icoria’s agricultural genotyping business to Monsanto, Inc.; and its Merger with Clinical Data, Inc. (NASDAQ: CLDA).

    Inteq Corporation
    Neil represented this venture capital backed information technology company in its sale to Computer Associates (NYSE:CA)

    iSkoot, Inc.
    Neil represented iSkoot, a mobile technology business, in three rounds of venture financing, multiple commercial arrangements with many of the world’s largest telecommunications companies, and its sale to Qualcomm, Inc. (NASDAQ: QCOM).

    J. P. Sercel, Inc.
    Neil represented J.P. Sercel, Inc., a developer of complex semiconductor inspection equipment, in its sale of IPG Photonics, Inc.

    NEXX Systems, Inc
    Neil represented NEXX Systems, a developer of semiconductor capital equipment, in its management buy-out from MKS Instruments, Inc. (NASDAQ:MKSI), multiple rounds of venture financing and bank financing, joint ventures with several of the world’s largest semiconductor companies, its proposed initial public offering, and its sale to Tokyo Electron for $204 million.

    PLC Systems, Inc.
    Neil has represented PLC (NASDAQ:PLCF) in its initial public offering, the sale of two business units, equity and debt financing arrangements and its ongoing securities law matters.

    Thermo-Electron (NYSE: TMO)
    Neil represented Thermo Electron in connection with several “going private” transactions for publicly traded affiliates of Thermo-Electron and in connection with the sale of four operating subsidiaries in the fields of commercial lasers, natural gas and biomass electrical generation facilities, rocket engineering and oil and gas services.

    Neil represented Y-Med, a medical device company founded in Israel, in several rounds of venture financing, major distribution agreements and its sale to C.R. Bard (NYSE:BCR)

    Venture Capital
    Neil has represented a number of venture capital and private equity investors including Highland Capital Corporation, Massachusetts Technology Collaborative, North Bridge Ventures and Watermill Ventures.

    Professional & Community Involvement

    Neil is a frequent lecturer at the MIT Sloan School of Management, a number of local university MBA programs and has spoken before a host of organizations including: National Association of Corporate Directors; Financial Executives International; Licensing Executives Society; Massachusetts Technology Leadership Council; Massachusetts Biotechnology Council; and the MIT Enterprise Forum.